Alpha interferon combined with ribavirin potentiates proliferative suppression but not cytokine production in mitogenically stimulated human lymphocytes-Reference-Cited by-同舟云学术

Alpha interferon combined with ribavirin potentiates proliferative suppression but not cytokine production in mitogenically stimulated human lymphocytes

Published:2000-11 Issue:2 Volume:48 Page:91-99
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Shiffman Mitchell L.,Verbeke Scott B.,Kimball Pamela M.

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference31 articles.

1. Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial;Bodenheimer;Hepatology,1997

2. Comparison of 1 or 3 Mu of interferon alpha-2b and placebo in patients with chronic non-A, non-B hepatitis;Causse;Gastroenterology,1991

3. The mechanisms of chronicity in hepatitis C virus infection;Chang;Gastroenterology,1998

4. Drug-drug interaction between cyclosporine and agents affecting calcium-dependent lymphocyte proliferation;Colombani;Transplant Proc.,1989

5. Treatment of chronic hepatitis C with recombinant interferon alpha: a multicenter, randomized, controlled trial;Davis;New Engl. J. Med.,1989

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ocular Surface Changes With Sofosbuvir in Egyptian Patients With Hepatitis C Virus Infection;Cornea;2016-03

2. Cryptococcal meningitis in a patient with chronic hepatitis C treated with pegylated-interferon and ribavirin;The Korean Journal of Internal Medicine;2014

3. Ribavirin ameliorates experimental autoimmune encephalomyelitis in rats and modulates cytokine production;International Immunopharmacology;2008-09

4. Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus;Journal of Viral Hepatitis;2008-01-10

5. The Prevalence, Clinical Features and Response to Antiviral Therapy of Patients with Chronic Hepatitis C who are Seropositive for Liver–Kidney Microsome Type 1 Antibodies;Antiviral Therapy;2005-08